COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,159 Articles (22,703 medRxiv, 8,456 bioRxiv)

Most recent first Previous |  Page 2086: Articles 20851-20860  | Next

Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals
Mahajan, S., Bhojak, K., Kode, V., Magdalene, C. M., Manoharan, M., Lee, K., Ramesh, A., V, S. H., Srivastava, A., Sathian, R., Kumar, P., Khan, T., Chakraborty, P., Chaudhuri, A.
10.1101/2020.11.03.367375 — Posted: 2020-11-05
SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice
Pollet, J., Chen, W.-H., Versteeg, L., Keegan, B., Zhan, B., Wei, J., Liu, Z., Lee, J., Kundu, R., Adhikari, R., Poveda, C., Villar Mondragon, M. J., de Araujo Leao, A. C., Altieri Rivera, J., Gillespie, P. M., Strych, U., Hotez, P. J., Bottazzi, M. E.
10.1101/2020.11.04.367359 — Posted: 2020-11-05
Evolution of Antibody Immunity to SARS-CoV-2
Gaebler, C., Wang, Z., Lorenzi, J. C. C., Muecksch, F., Finkin, S., Tokuyama, M., Ladinsky, M., Cho, A., Jankovic, M., Schaefer-Babajew, D., Oliveira, T. Y., Cipolla, M., Viant, C., Barnes, C. O., Hurley, A., Turroja, M., Gordon, K., Millard, K. G., Ramos, V., Schmidt, F., Weisblum, Y., Jha, D., Tankelevich, M., Yee, J., Shimeliovich, I., Robbiani, D. F., Zhao, Z., Gazumyan, A., Hatziioannou, T., Bjorkman, P. J., Mehandru, S., Bieniasz, P. D., Caskey, M., Nussenzweig, M. C.
10.1101/2020.11.03.367391 — Posted: 2020-11-05 Discussion: Onsite
Risk perceptions and preventive practices of COVID-19 among healthcare professionals in public hospitals in Ethiopia
Deressa, W., Worku, A., Abebe, W., Gizaw, M., Amogne, W.
10.1101/2020.11.04.367896 — Posted: 2020-11-04 Discussion: Offsite
COVID-19 in Hospitalized Ethiopian Children: Characteristics and Outcome Profile
Leulseged, T. W., Hassen, I. S., Maru, E. H., Zewde, W. C., Chamiso, N. W., Edo, M. G., Abebe, D. S., Aliy, M. A.
10.1101/2020.10.30.20223115 — Posted: 2020-11-04
Immune modulating drug MP1032 with SARS-CoV-2 antiviral activity in vitro: A potential multi-target approach for prevention and early intervention treatment of COVID-19.
Schumann, S., Kaiser, A., Nicoletti, F., Mangano, K., Fagone, P., van Wijk, E., Yan, Y., Schulz, P., Ludescher, B., Niedermaier, M., von Wegerer, J., Rauch, P., Setz, C., Schubert, U., Brysch, W.
10.1101/2020.11.03.20216580 — Posted: 2020-11-04
Benefits and risks of zinc for adults during covid-19: rapid systematic review and meta-analysis of randomised controlled trials.
Hunter, J., Arentz, S., Goldenberg, J., Mertz, D., Yang, G., Beardsley, J., Myers, S. P., Leeder, S.
10.1101/2020.11.02.20220038 — Posted: 2020-11-04
Experiences of living with mental health problems during the COVID-19 pandemic in the UK: a coproduced, participatory qualitative interview study
Gillard, S., Dare, C., Hardy, J., Nyikavaranda, P., Rowan Olive, R., Shah, P., Birken, M., Foye, U., Ocloo, J., Pearce, E., Stefanidou, T., Pitman, A., Simpson, A., Johnson, S., Lloyd-Evans, B., COVID Coproduction Research Group, N. M. H. P. R. U.
10.1101/2020.11.03.20225169 — Posted: 2020-11-04 Discussion: Offsite
Household Transmission of SARS-COV-2: Insights from a Population-based Serological Survey
Bi, Q., Lessler, J., Eckerle, I., Lauer, S. A., Kaiser, L., Vuilleumier, N., Cummings, D. A., Flahault, A., Petrovic, D., Guessous, I., Stringhini, S., Azman, A. S., SEROCoV-POP
10.1101/2020.11.04.20225573 — Posted: 2020-11-04 Discussion: Offsite
Delirium and Post-Discharge Neuropsychological Outcomes in Critically Ill Patients with COVID-19: an Institutional Case Series
Ragheb, J., McKinney, A., Zierau, M., Brooks, J., Hill-Caruthers, M., Iskander, M., Ahmed, Y., Lobo, R., Vlisides, P. E.
10.1101/2020.11.03.20225466 — Posted: 2020-11-04 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).